Oxy Low Carbon Ventures (OLCV) and TAE Technologies signed a memorandum to explore using TAE’s fusion technology for emissions-free power and heat in Direct Air Capture (DAC) facilities. The partnership aims to integrate fusion energy with Occidental’s clean energy sources for DAC operations.
Earning the BioTech Breakthrough Award for Oncology Innovation of the Year validates the progress TAE Life Sciences has made in readying its Alphabeam BNCT system for clinical trials worldwide
North Carolina has enacted landmark energy legislation that recognizes fusion technology’s safety and environmental benefits. Senate Bill 678 demonstrates the state’s commitment to investing in fusion as a new clean electricity source that can be an important part of the state’s energy mix.
Assembly Bill 1172 supports California’s fusion energy industry by recognizing this cutting-edge technology’s safety and environmental benefits while setting the stage for the state’s future regulatory framework.
TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, is thrilled to announce it is bringing BNCT to this year’s annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.
TAE Life Sciences, a pre-clinical stage biotech company focused on advancing the field of radiation oncology through accelerator-based Boron Neutron Capture Therapy (BNCT), announces the appointment of Rob Hill as its new Chief Executive Officer (CEO). Hill succeeds Bruce Bauer, a co-founder of TAE Life Sciences, who served as the company’s CEO since it was founded in 2017.